Rankings
▼
Calendar
SRPT Q1 2019 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$87M
+34.7% YoY
Gross Profit
$75M
86.1% margin
Operating Income
-$76M
-87.8% margin
Net Income
-$77M
-88.1% margin
EPS (Diluted)
$-1.07
QoQ Revenue Growth
+3.1%
Cash Flow
Operating Cash Flow
-$146M
Free Cash Flow
-$163M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$615M
Stockholders' Equity
$1.3B
Cash & Equivalents
$732M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$87M
$65M
+34.7%
Gross Profit
$75M
$59M
+27.0%
Operating Income
-$76M
-$31M
-148.5%
Net Income
-$77M
-$35M
-116.7%
← FY 2019
All Quarters
Q2 2019 →